Get started
Author

R. Greil

Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.
1997 · A Villunger, A Egle, et al. · PubMed · 170
Necrotizing Vasculitis Associated with Hepatitis C Virus Infection: Successful Treatment of Vasculitis with Interferon-Alpha despite Persistence of Mixed Cryoglobulinemia
2009 · N.T. Sepp, F. Umlauft, et al. · Dermatology · 19
Twelve-year retrospective analysis of lung cancer—The TYROL Study: Daily routine in 1,424 patients (1995–2006)
2008 · M. Fiegl, W. Hilbe, et al. · Journal of Clinical Oncology · 18
659MO Pembrolizumab with or without chemotherapy for first-line treatment of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): 5-year results from KEYNOTE-048
2022 · M. Tahara, R. Greil, et al. · Annals of Oncology · 17
PDF
Oxaliplatin, irinotecan, and cetuximab in advanced gastric cancer. First efficacy results of a multicenter phase II trial (AGMT Gastric-2) of the Arbeitsgemeinschaft Medikamentoese Tumortherapie (AGMT)
2009 · E. Woell, R. Greil, et al. · Journal of Clinical Oncology · 15
Ropeginterferon alfa-2b for the treatment of patients with polycythemia vera
2020 · Wagner, S.M., Melchardt, T., et al. · Drugs of today · 14
Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer: First results of a multicenter phase II trial (AGMT Gastric- 2
2008 · E. Woell, R. Greil, et al. · Journal of Clinical Oncology · 13
Analysis of the effects of vitamin K1 cream on cetuximab-induced acne-like rash.
2010 · N. Radovics, G. Kornek, et al. · Journal of Clinical Oncology · 8
Assessment of TP 53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC ‐wide approach
2014 · G. Doreen te Raa, Jitka Malčiková, et al. · British Journal of Haematology · 7
PDF
Ps1161 Efficacy and Safety of Ibrutinib in Relapsed/refractory Chronic Lymphocytic Leukemia Patients Previously Treated With Venetoclax in the Murano Study
2019 · R. Greil, G. Fraser, et al. · HemaSphere · 4
Ibrutinib Decreases Obinutuzumab‐induced Secretion of Cytokines Associated With Infusion‐related Reactions in Patients With Cll: Analysis From the Illuminate Study
2019 · R. Greil, A. Tedeschi, et al. · Hematological Oncology · 4
MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis
2014 · A. Benner, L. Mansouri, et al. · Haematologica · 4
PDF
100 Overall survival data of patients with MDS, AML and CMML from the Austrian Azacitidine Registry of 184 consecutive patients
2011 · L. Pleyer, R. Stauder, et al. · Leukemia Research · 3
101 Age- and comorbidity-specific evaluation of azacitidine treatment, response and overall survival in 184 patients in the Austrian Azacitidine Registry
2011 · L. Pleyer, R. Stauder, et al. · Leukemia Research · 3
[Rhabdomyolysis as a late complication of anesthesia--a case of malignant hyperthermia?].
1985 · R Greil, C Gattringer, et al. · PubMed · 3
Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab
2019 · T. Magnes, T. Melchardt, et al. · The Pharmacogenomics Journal · 2
PDF
Good Response of Lupus Hepatitis to Mycophenolate Mofetil and Belimumab as of Lupus Exanthema to Rituximab: A Case Report
2019 · Psenak O, Studnicka-Benke A, et al. · Rheumatology Current Research · 2
114 Vinorelbine/gemcitabine in advanced non-small-cell lung cancer (NSCLC): A phase I trial
1997 · R. Pirker, G. Krajnik, et al. · Lung Cancer · 2
273 | Real‐world Outcomes of Pirtobrutinib in Relapsed/refractory Mantle Cell Lymphoma: a Multicenter Analysis With a Control Cohort From the European Mcl Registry
2025 · E. Aydilek, F. Schwarz, et al. · Hematological Oncology · 1
PDF
Detection of Anti-drug Antibodies in Patients with Acquired Hemophilia A: Data from the GTH-AHA-EMI Study
2025 · E I Ertekin, A Klingberg, et al. · Hämostaseologie · 1
アジュバント内分泌療法へのゾレドロン酸(zol)追加はホルモン応答性早期乳房腫瘍(hrebc)の閉経前女性の無病生存(df)及び非再発生存(rfs)を改善する:オーストリア乳房腫瘍及び結腸直腸腫瘍研究グループ12(abcsg-12)試験の多変量解析
2009 · Michael Gnant, B Mineritsch, et al. · Annals of Oncology · 1
FXIa-Triggered Thrombin Generation to Predict Breakthrough Bleeding in Acquired Hemophilia A: Data from the GTH-AHA-EMI Study
2025 · S Werwitzke, F Pelzer, et al. · Hämostaseologie
42P Endothelin-1 genetic polymorphism (SNP rs5370-TT) fails to predict resistance to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial
2022 · S.P. Gampenrieder, M. Steiner, et al. · Annals of Oncology
S840 Impact of 1st Line Treatment on Overall Survival in 1.633 Patients With Chronic Myelomonocytic Leukemia – a Multinational Collaborative Effort Coordinated by the Agmt Study Group
2019 · L. Pleyer, M. Leisch, et al. · HemaSphere
Ps1509 Quality of Life in Patients With Rrmm During Ixa-thal-dex Induction and Ixazomib Maintenance Therapy in Comparison to the General Population
2019 · H. Ludwig, W. Pönisch, et al. · HemaSphere
Works count: 42
Citation count: 311
H-index: 8
I10-index: 7
Year
Topic
Type